收稿日期: 2023-08-09
修回日期: 2023-11-06
网络出版日期: 2024-03-12
Current situation of capacity building for key parasitic diseases control in CDCs of China
Received date: 2023-08-09
Revised date: 2023-11-06
Online published: 2024-03-12
目的 了解全国疾病预防控制机构(简称疾控机构)重点寄生虫病防治队伍建设现状、技术需求,并提出针对性改进建议。方法 采用线上问卷调查方式,对全国省、市、县级疾控机构和寄生虫病/血吸虫病防治机构开展寄生虫病防治专业人员基本情况、实验室检测能力、技术培训及队伍建设需求等调查,使用SPSS 26.0统计学软件进行统计分析。结果 共有1 855个省、市、县级疾控机构参与调查,在岗人员共122 282人,其中参与寄生虫病防治工作的人员(简称寄防人员)共计8 943人,占全部在岗人员的7.31%(8 943/122 282);专职寄防人员4 745人,占寄防人员的53.06%(4 745/8 943)。参与调查的疾控机构中,东部地区高级职称及研究生学历占比(19.92%、13.52%)均高于中部(17.02%、8.29%)和西部(13.88%、8.25%)地区(χ2 = 1 063.60、 2 892.89, P < 0.01);东部地区寄防人员高级职称及研究生学历占比(21.20%、12.51%)也高于中部(15.63%、7.30%)和西部(11.62%、6.57%)地区(χ2 = 142.19、314.93,均P < 0.01)。各级疾控机构寄防人员日常工作侧重不同,近一年开展的对下一级寄生虫病防治业务培训2 207次,省级机构平均2.7次,地市级平均1.4次,县级平均1.1次。省、市、县3级分别有12.50%(4/32)、34.02%(83/244)和49.02%(774/1 579)的疾控机构未设有寄生虫病专用实验室。在血吸虫病、棘球蚴病和内脏利什曼病重点流行省(直辖市、自治区),掌握各病种检测能力的机构占比分别为55.90%(398/712)、40.22%(218/542)和14.55%(117/804),均高于非流行省(直辖市、自治区)(29.83%、7.77%、6.95%)(χ2 = 124.36、 283.05、 28.67,均P < 0.01)。各级疾控机构对寄生虫病防治工作需求相对集中在人员业务培训(34.61%,642/1 855)、诊断检测技术(12.40%,230/1 855)和经费设备投入(5.44%,101/1 855)等方面。结论 全国疾控机构寄生虫病防治能力不平衡,应继续优化寄生虫病防治人员结构、加强业务培训和实验室检测能力建设,为控制和消除寄生虫病提供人才队伍保障。
郝瑜婉 , 田添 , 朱泽林 , 陈怡君 , 朱慧慧 , 王强 , 李石柱 , 周晓农 . 全国疾控机构重点寄生虫病防治能力建设现状分析[J]. 中国寄生虫学与寄生虫病杂志, 2024 , 42(1) : 83 -90 . DOI: 10.12140/j.issn.1000-7423.2024.01.012
Objective To understand the current situation of capacitity building in team development and technical needs and to propose pertinent improvement suggestion for key parasitic disease control in the centers for disease control and prevention (CDC) at all levels in China. Methods An on-line questionnaire survey was performed to collect information on the professional staff structure, technique training, laboratory testing capability, and technology needs for parasitic disease control in the CDCs and schistosomioasis control institutions at all levels. The data was analyzed using SPSS 26.0 software. Results A total of 1 855 (provincial, municipal and county) CDCs participated in the survey. Among 122 282 technicians on duty, 7.31% (8 493/122 282) were responsible for parasitic disease control. A total of 4 745 are full-time, accounting for 53.06% (4 745/8 943) of all staff working on parasite disease control. There were significant differences in the distribution of professional titles and educational levels among employees working in CDCs. Higher proportions of senior professional titles and postgraduate degrees were found in the eastern region (19.92%, 13.52%) than in the central (17.02%, 8.29%) and western region (13.88%, 8.25%) (χ2 = 1 063.60, 2 892.89;both P < 0.01). The proportion of senior professional titles and postgraduate education among the personnel involved in parasitic disease prevention and control were also higher in the eastern region (21.20%, 12.51%) compared to the central region (15.63%, 7.30%) and western region (11.62%, 6.57%) (χ2 = 142.19, 314.93; both P < 0.01). The daily tasks of disease control agency staff at all levels have varying emphases. During the past year, 2 207 technical trainings were given to subordinate CDCs. On average, each individual at provincial CDCs has taken 2.7 training courses, each individual at city-level CDCs has taken 1.4 training courses, and each individual at county-level CDCs has taken 1.1 training courses. There were 12.50% (4/32) of province-level CDCs, 34.02% (83/244) of city-level CDCs and 49.02% (774/1 579) of county-level CDCs without specific laboratories for parasitic diseases. 55.90% (398/712), 40.22% (218/542) and 14.55% (117/804) of CDCs performed the ability for diagnosis of schistosomiasis, echinococcosis and visceral leishmaniasis in provinces where the disease is endemic, and the proportions were higher than those in non-endemic provinces (29.83%, 7.77%, 6.95%)(χ2 = 124.36, 283.05, 28.67; all P < 0.01). In addition, the requirements of CDCs mainly focused on personnel training (34.61%, 642/1 855), diagnosing and testing technology (12.40%, 230/1 855), and financial and equipment inputs (5.44%, 101/1 855). Conclusion The CDCs at all levels in the country show capability imbalance in parasitic disease control. Therefore, it is imperative to continuously optimize personnel structure, strengthen professional training and capacity building for laboratory testing, ensuring adequate personnel support for the control and elimination of parasitic diseases.
| [1] | Xiao N, Li SZ, Qian MB, et al. Contribution of NIPD-CTDR to the parasitic diseases control and elimination in China: memory of the 70th anniversary for NIPD-CTDR[J]. Adv Parasitol, 2020, 110: 401-427. |
| [2] | Lv S Xu J, Cao CL, et al. China fighting against schistosomiasis for 70 years: progress and experience[J]. Chin J Parasitol Parasit Dis, 2019, 37(5): 514-519. (in Chinese) |
| (吕山, 许静, 曹淳力, 等. 我国血吸虫病防治70年历程与经验[J]. 中国寄生虫学与寄生虫病杂志, 2019, 37(5): 514-519.) | |
| [3] | Chen JH, Fen J, Zhou XN. From 30 million to zero malaria cases in China: lessons learned for China-Africa collaboration in malaria elimination[J]. Infect Dis Poverty, 2021, 10: 51. |
| [4] | Sun DJ, Fang Y, Huang Y, et al. Contributions to the lymphatic filariasis elimination programme and post-elimination surveillance in China by NIPD-CTDR[J]. Adv Parasitol, 2020, 110: 145-183. |
| [5] | Feng J, Zhang L, Tu H, et al. From elimination to post-elimination: characteristics, challenges and re-transmission preventing strategy of imported malaria in China.[J]. Chin Trop Med, 2021, 21(1): 5-10. (in Chinese) |
| (丰俊, 张丽, 涂宏, 等. 从消除到消除后: 中国输入性疟疾的疫情特征、挑战及防止再传播策略[J]. 中国热带医学. 2021, 21(1): 5-10.) | |
| [6] | Zhang LJ, Li SZ, Li YL, et al. Interpretation of work plan for pilot counties to promote the elimination of schistosomiasis(2023 edition)[J]. J Trop Dis Parasitol, 2023, 21(3): 121-125. (in Chinese) |
| 张利娟, 李仕祯, 李银龙, 等. 《血吸虫病消除推进试点县工作方案(2023年版)》解读[J]. 热带病与寄生虫学, 2023, 21(3): 121-125.) | |
| [7] | Fu MH, Han S, Xue CZ, et al. Contribution to the echinococcosis control programme in China by NIPD-CTDR[J]. Adv Parasitol, 2020, 110: 107-144. |
| [8] | Luo ZW, Zhou ZB, Gong YF, et al. Current status and challenges of visceral leishmaniasis in China[J]. Chin J Parasitol Parasit Dis, 2022, 40(2): 146-152. (in Chinese) |
| (罗卓韦, 周正斌, 公衍峰, 等. 我国内脏利什曼病的流行现状和防控挑战[J]. 中国寄生虫学与寄生虫病杂志, 2022, 40(2): 146-152.) | |
| [9] | Chen YD, Huang JL, Zhu HH, et al. China’s control process of soil-transmitted helminth infections from pandemic to low-endemic levels[J]. Chin J Parasitol Parasit Dis, 2019, 37(4): 395-398. (in Chinese) |
| (陈颖丹, 黄继磊, 朱慧慧, 等. 我国土源性线虫从高感染到低感染水平的防治历程[J]. 中国寄生虫学与寄生虫病杂志, 2019, 37(4): 395-398.) | |
| [10] | Wang LY, Qin M, Gavotte L, et al. Societal drivers of human echinococcosis in China[J]. Parasit Vectors, 2022, 15(1): 385. |
| [11] | Wang LD. Opportunities and challenges of “healthy China 2030”[J]. Sci Technol Rev, 2018, 36(22): 8-11. (in Chinese) |
| (王陇德. “健康中国2030”的机遇与挑战[J]. 科技导报, 2018, 36(22): 8-11.) | |
| [12] | National Health Commission. China health statistical yearbook 2022[M]. Beijing: Peking Union Medical College Press, 2022: 1-2. (in Chinese) |
| (国家卫生健康委员会. 《2022中国卫生健康统计年鉴》[M]. 北京: 中国协和医科大学出版社, 2022: 1-2.) | |
| [13] | Sun DJY, Li LM. Summary and recommendations of development of public health and disease prevention and control[J]. Bull Chin Acade of Sci, 2020, 35(9): 1096-1104. (in Chinese) |
| (孙点剑一, 李立明. 浅谈公共卫生与疾病预防控制体系建设[J]. 中国科学院院刊, 2020, 35(9): 1096-104.) | |
| [14] | Gao ZM. On the leading role of public health and preventive medicine in the construction of Healthy China[J]. J Public Heath Prev Med, 2019, 30(5): 5-10. (in Chinese) |
| (高忠明. 公共卫生与预防医学在健康中国建设中的引领作用[J]. 公共卫生与预防医学, 2019, 30(5): 5-10.) | |
| [15] | Liu X, Wang L, Chen YF, et al. Thoughts on the reform of disease prevention and control system in China[J]. Chin J Public Heath Manag, 2020, 36(2): 145-148. (in Chinese) |
| (刘霞, 王岚, 陈毅峰, 等. 中国疾病预防控制体系改革的思考[J]. 中国公共卫生管理, 2020, 36(2): 145-148.) | |
| [16] | Wu F, Chen Y, Fu C, et al. Key issues and recommendations on restructuring China’s disease control and prevention system[J]. Chin Heath Resour, 2020, 23(3): 185-190, 294. (in Chinese) |
| (吴凡, 陈勇, 付晨, 等. 中国疾病预防控制体系发展改革的若干问题与对策建议[J]. 中国卫生资源, 2020, 23(3): 185-190, 294.) | |
| [17] | Wu QWQ, Huang LY, Liu Y, et al. Present situation and suggestions on the construction of talent team in disease prevention and control institutions in China[J]. Chin J Public Heath Manag, 2021, 37(2): 165-168. (in Chinese) |
| (吴琼文倩, 黄烈雨, 刘杨, 等. 中国疾病预防控制机构人才队伍建设现状及建议[J]. 中国公共卫生管理, 2021, 37(2): 165-168.) | |
| [18] | Liu CH, Yue YT, Wang YK. Exploration and thoughts on the capacity construction of provincial disease control and prevention institutions in the new era: a case study in Henan Center for Disease Control and Prevention[J]. Mod Dis Contr Prev, 2023, 34(6): 448-451. (in Chinese) |
| (刘翠华, 岳义田, 王艺康. 新时代省级疾控机构能力建设的思考: 以河南省疾病预防控制中心为例[J]. 现代疾病预防控制, 2023, 34(6): 448-451.) | |
| [19] | Xu J, Cao CL, Lü S, et al. Schistosomiasis control in China from 2012 to 2021: progress and challenges[J]. Chin J Schisto Control, 2022, 34(6): 559-565, 579. (in Chinese) |
| (许静, 曹淳力, 吕山, 等. 血吸虫病防治这10年: 进展与挑战[J]. 中国血吸虫病防治杂志, 2022, 34(6): 559-565, 579.) | |
| [20] | Liu NN, Huang LY, Liu Y, et al. Analysis of the personnel outflow in Chinese center for disease control and prevention from 2014 to 2021[J]. Chin Heath Serv Manag, 2023, 40(4): 289-291, 296. (in Chinese) |
| (刘娜娜, 黄烈雨, 刘杨, 等. 2014—2021年中国疾病预防控制中心人员流出情况分析[J]. 中国卫生事业管理, 2023, 40(4): 289-291, 296.) | |
| [21] | Kui Y, Cao CL, Tian S, et al. Evaluation on human resource allocation in certain national institute of parasitic diseases in ten years[J]. Chin J Schisto Control, 2017, 29(2): 197-201. (in Chinese) |
| (蒉嫣, 曹淳力, 田申, 等. 我国国家级寄生虫病预防控制机构人才队伍十年发展评价[J]. 中国血吸虫病防治杂志, 2017, 29(2): 197-201.) | |
| [22] | Yin JH, Li M, Yan H, et al. Laboratory diagnosis for malaria in the elimination phase in China: efforts and challenges[J]. Front Med, 2022, 16(1): 10-16. |
| [23] | Qin ZQ, Xu J, Feng T, et al. Strategic thinking of the construction of national schistosomiasis laboratory network in China[J]. Chin J Schisto Control, 2013, 25(4): 329-332. (in Chinese) |
| (秦志强, 许静, 冯婷, 等. 全国血吸虫病诊断网络平台建设及思考[J]. 中国血吸虫病防治杂志, 2013, 25(4): 329-332.) | |
| [24] | Wang Q, Xu J, Hao YW, et al. Assessment on the diagnostic capacity for parasitic diseases of health facilities: China, 2019[J]. China CDC Wkly, 2021, 3(35): 731-735. |
| [25] | Xu J, Li SZ, Guo JG, et al. The WHO new guideline to control and eliminate human schistosomiasis: implications for the verification of transmission interruption and surveillance of Schistosoma japonicum in China[J]. Infect Dis Poverty, 2022, 11(1): 79. |
| [26] | Chen JX, Cai YC, Ai L, et al. Epidemic status and challenges of important human parasitic diseases in China[J]. Lab Med, 2021, 36(10): 993-1000. (in Chinese) |
| (陈家旭, 蔡玉春, 艾琳, 等. 我国重要人体寄生虫病防控现状与挑战[J]. 检验医学, 2021, 36(10): 993-1000.) | |
| [27] | Casulli A. New global targets for NTDs in the WHO roadmap 2021—2030[J]. PLoS Negl Trop Dis, 2021, 15(5): e0009373. |
| [28] | Engels D, Zhou XN. Neglected tropical diseases: an effective global response to local poverty-related disease priorities[J]. Infect Dis Poverty, 2020, 9: 10. |
| [29] | Gong YF, Li YL, Zhang LJ, et al. The potential distribution prediction of Oncomelania hupensis based on newly emerging and reemergent habitats: China, 2015—2019[J]. China CDC Wkly, 2021, 3(5): 90-93. |
| [30] | Hao YW, Hu XK, Gong YF, et al. Spatio-temporal clustering of mountain-type zoonotic visceral leishmaniasis in China between 2015 and 2019[J]. PLoS Negl Trop Dis, 2021, 15(3): e0009152. |
| [31] | Zhu HH, Huang JL, Zhou CH, et al. Soil-transmitted helminthiasis in Chinese mainland from 2016 to 2020: a population-based study[J]. Lancet Reg Health West Pac, 2023, 36: 100766. |
| [32] | Hao YW, Luo ZW, Zhao JA, et al. Transmission risk prediction and evaluation of mountain-type zoonotic visceral leishmaniasis in China based on climatic and environmental variables[J]. Atmosphere, 2022, 13(6): 964. |
/
| 〈 |
|
〉 |